Laguna Beach, CA, United States of America

K George Chandy

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 52(Granted Patents)


Location History:

  • Irvine, CA (US) (2010)
  • Laguna Beach, CA (US) (2000 - 2018)

Company Filing History:


Years Active: 2000-2018

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: K George Chandy: Innovator in Obesity Treatment

Introduction

K George Chandy is a prominent inventor based in Laguna Beach, CA (US). He has made significant contributions to the field of pharmacology, particularly in the treatment of obesity and related disorders. With a total of 12 patents to his name, Chandy's work focuses on innovative approaches to target potassium channels for therapeutic purposes.

Latest Patents

Chandy's latest patents include groundbreaking methods for treating obesity and obesity-related disorders by pharmacologically targeting Kv1.3 potassium channels. One of his notable inventions involves the activation of brown adipose tissue, which can be achieved by administering a potassium channel inhibiting agent. This agent may consist of ShK toxin or a modified version of it, such as ShK-186. Additionally, he has developed analogs of ShK toxin that are designed for selective inhibition of Kv1.3 potassium channels, which can be utilized in treating various diseases and disorders. These analogs may also include a fluorophore, allowing for advanced applications in flow cytometry.

Career Highlights

Throughout his career, K George Chandy has worked with esteemed institutions such as the University of California and the University of Florida Research Foundation. His research has significantly advanced the understanding of potassium channels and their role in obesity treatment.

Collaborations

Chandy has collaborated with notable colleagues, including J Jay Gargus and Heike Wulff, contributing to the development of innovative solutions in his field.

Conclusion

K George Chandy's contributions to the treatment of obesity through innovative pharmacological methods highlight his role as a leading inventor in this area. His work continues to pave the way for new therapeutic approaches that could benefit many individuals suffering from obesity-related disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…